SWOG clinical trial number
SWOG-9148
A Phase II Study of Cisplatin Preceded By A 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) For Patients with Untreated, Extensive Stage Small Cell and Non-Small Cell Lung Carcinoma
Closed
Phase
Accrual
58%
Abbreviated Title
A Phase II Study of Cisplatin Preceded By A 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) For Patients with Untreated, Extensive Stage Small Cell and Non…
Activated
09/01/1992
Closed
06/01/1995